Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia

21 Jul 2017

Abstract excerpt

Chronic lymphocytic leukemia (CLL) is a slowly developing progression-prone disease. MicroRNAs miR-155 and miR-150 are small inhibitors of gene expression in B-cells that were previously connected to the pathogenesis of CLL. We herein evaluated relationship of miR-155/miR-150 network with clinical and routine laboratory parameters of the CLL patient cohort utilizing multivariate analyses and found its association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Galectins and Cancer Biology
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28731457
DOI: 10.1038/bcj.2017.63

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemiaPMID 28731457Read ↗

[Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia].Semantic proximity Read ↗

Role of microRNAs in Chronic Lymphocytic Leukemia PathogenesisSemantic proximity Read ↗

microRNA and Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

Role of microRNA in chronic lymphocytic leukemia onset and progressionSemantic proximity Read ↗

Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genesSemantic proximity Read ↗

microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.Semantic proximity Read ↗

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Role of microRNAs in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor PrognosisSemantic proximity Read ↗

RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcomeSemantic proximity Read ↗

MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.